Multiple studies have demonstrated significant pharmacokinetic advantages for IP chemotherapy in patients. Clinical research on intraperitoneal therapy IP therapy has been under development for ...

The SUNCHIP System was specifically developed for Hyperthermic IntraPeritoneal Chemotherapy System (HIPEC), based on the recommendations of Dr. Dominique Elias (department of general oncology ...

preferred chemotherapy regimens, timing of interval cytoreductive surgery (ICS), hyperthermic intraperitoneal chemotherapy (HIPEC), post ICS-chemotherapy, maintenance therapy, and options for those ...

A 60-year-old man from the Cadillac area has become the first patient in Michigan to receive a state-of-the-art aerosolized cancer treatment, performed by Henry Ford Health surgical oncologist Dr.

At City of Hope, Dr. Raoof is part of one of the largest programs in the region performing complex cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for cancers that have ...

HIPEC, or Hyperthermic Intraperitoneal Chemotherapy, is a surgical procedure where chemotherapy is heated and then directly infused into the abdominal cavity after the cancer along with involved ...

“This is the first positive phase 3 multicenter RCT [randomized controlled trial] to definitively show the survival advantage of IP [intraperitoneal] chemotherapy, providing robust evidence to ...

After undergoing three cycles of chemotherapy in Srinagar without improvement, he sought treatment at Fortis Hospital Mohali ...